To investigate molecular biomarkers differentially regulated in TMPRSS2–ERG fusion-positive tumours, significance testing was conducted using significance analysis of microarrays (Tusher et al, 2001) for both the Toronto cohort and that of the 455-patient Swedish cohort (Setlur et al, 2008). This evidence concerns the gene TMPRSS2 and neoplasm.